FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018093749> ?p ?o ?g. }

• W2018093749 endingPage "576" @default.
• W2018093749 startingPage "569" @default.
• W2018093749 abstract "The aim of this study was to investigate the clinical efficacy of oral Pycnogenol (Horphag Research Ltd, UK) in patients with severe chronic venous insufficiency. Patients with severe venous hypertension (chronic venous insufficiency, ankle swelling) and history of venous ulcerations were treated with Pycnogenol. Patients received oral Pycnogenol (50 mg capsules, 3 times daily for a total of 150 mg daily) for 8 weeks. A group of 21 patients was included in the treatment group and 18 equivalent patients were observed as controls (no treatment during the observation period). All 21 patients (age 53 years; range, 42-60 years; M:F=11:10) in the treatment group completed the 8-week study. Also the 18 controls completed the follow-up period. There were no drop-outs. The average ambulatory venous pressure was 59.3 (SD 7.2; range 50-68) with a refilling time shorter than 10 seconds (average 7.6; SD 3). There were no differences in ambulatory venous pressure or refilling time between the treatment and control patients. The duration of the disease-from the first signs/symptoms-was on average 5.7 years (SD 2.1). At 4 and 8 weeks, in all Pycnogenol-treated subjects, microcirculatory and clinical evaluations indicated a progressive decrease in skin flux, indicating an improvement in the level of microangiopathy; a significant decrease in capillary filtration; a significant improvement in the symptomatic score; and a reduction in edema. There were no visible effects in controls. In conclusion, this study confirms the fast clinical efficacy of Pycnogenol in patients with chronic venous insufficiency and venous microangiopathy. The study indicates the significant clinical role of Pycnogenol in the management, treatment and control of this common clinical problem. The treatment may be also useful to prevent ulcerations by controlling the level of venous microangiopathy." @default.
• W2018093749 created "2016-06-24" @default.
• W2018093749 creator A5007743014 @default.
• W2018093749 creator A5008403575 @default.
• W2018093749 creator A5015975252 @default.
• W2018093749 creator A5021408127 @default.
• W2018093749 creator A5024392515 @default.
• W2018093749 creator A5032439447 @default.
• W2018093749 creator A5042807286 @default.
• W2018093749 creator A5044057983 @default.
• W2018093749 creator A5047974987 @default.
• W2018093749 creator A5059012847 @default.
• W2018093749 creator A5059563610 @default.
• W2018093749 creator A5065600862 @default.
• W2018093749 creator A5065763260 @default.
• W2018093749 creator A5070275576 @default.
• W2018093749 creator A5085732626 @default.
• W2018093749 creator A5088585258 @default.
• W2018093749 creator A5088747812 @default.
• W2018093749 date "2006-10-01" @default.
• W2018093749 modified "2023-09-27" @default.
• W2018093749 title "Rapid Relief of Signs/Symptoms in Chronic Venous Microangiopathy With Pycnogenol®: A Prospective, Controlled Study" @default.
• W2018093749 cites W1969603189 @default.
• W2018093749 cites W1971860659 @default.
• W2018093749 cites W1977380820 @default.
• W2018093749 cites W1977698530 @default.
• W2018093749 cites W1982230297 @default.
• W2018093749 cites W1989403632 @default.
• W2018093749 cites W2013526705 @default.
• W2018093749 cites W2022683182 @default.
• W2018093749 cites W2027168075 @default.
• W2018093749 cites W2044115540 @default.
• W2018093749 cites W2045580391 @default.
• W2018093749 cites W2061102737 @default.
• W2018093749 cites W2063252794 @default.
• W2018093749 cites W2072172506 @default.
• W2018093749 cites W2090501982 @default.
• W2018093749 cites W2093686299 @default.
• W2018093749 cites W2095332322 @default.
• W2018093749 cites W2105054838 @default.
• W2018093749 cites W2125884842 @default.
• W2018093749 cites W2131279645 @default.
• W2018093749 cites W2150785731 @default.
• W2018093749 cites W2159220120 @default.
• W2018093749 cites W2161272181 @default.
• W2018093749 cites W4241104330 @default.
• W2018093749 doi "https://doi.org/10.1177/0003319706291392" @default.
• W2018093749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17067979" @default.
• W2018093749 hasPublicationYear "2006" @default.
• W2018093749 type Work @default.
• W2018093749 sameAs 2018093749 @default.
• W2018093749 citedByCount "39" @default.
• W2018093749 countsByYear W20180937492012 @default.
• W2018093749 countsByYear W20180937492013 @default.
• W2018093749 countsByYear W20180937492014 @default.
• W2018093749 countsByYear W20180937492015 @default.
• W2018093749 countsByYear W20180937492016 @default.
• W2018093749 countsByYear W20180937492017 @default.
• W2018093749 countsByYear W20180937492019 @default.
• W2018093749 countsByYear W20180937492020 @default.
• W2018093749 countsByYear W20180937492021 @default.
• W2018093749 countsByYear W20180937492023 @default.
• W2018093749 crossrefType "journal-article" @default.
• W2018093749 hasAuthorship W2018093749A5007743014 @default.
• W2018093749 hasAuthorship W2018093749A5008403575 @default.
• W2018093749 hasAuthorship W2018093749A5015975252 @default.
• W2018093749 hasAuthorship W2018093749A5021408127 @default.
• W2018093749 hasAuthorship W2018093749A5024392515 @default.
• W2018093749 hasAuthorship W2018093749A5032439447 @default.
• W2018093749 hasAuthorship W2018093749A5042807286 @default.
• W2018093749 hasAuthorship W2018093749A5044057983 @default.
• W2018093749 hasAuthorship W2018093749A5047974987 @default.
• W2018093749 hasAuthorship W2018093749A5059012847 @default.
• W2018093749 hasAuthorship W2018093749A5059563610 @default.
• W2018093749 hasAuthorship W2018093749A5065600862 @default.
• W2018093749 hasAuthorship W2018093749A5065763260 @default.
• W2018093749 hasAuthorship W2018093749A5070275576 @default.
• W2018093749 hasAuthorship W2018093749A5085732626 @default.
• W2018093749 hasAuthorship W2018093749A5088585258 @default.
• W2018093749 hasAuthorship W2018093749A5088747812 @default.
• W2018093749 hasConcept C126322002 @default.
• W2018093749 hasConcept C134018914 @default.
• W2018093749 hasConcept C141071460 @default.
• W2018093749 hasConcept C2776106345 @default.
• W2018093749 hasConcept C2776513394 @default.
• W2018093749 hasConcept C2779918671 @default.
• W2018093749 hasConcept C2780886150 @default.
• W2018093749 hasConcept C2910946596 @default.
• W2018093749 hasConcept C35785553 @default.
• W2018093749 hasConcept C555293320 @default.
• W2018093749 hasConcept C71924100 @default.
• W2018093749 hasConcept C84393581 @default.
• W2018093749 hasConcept C90924648 @default.
• W2018093749 hasConceptScore W2018093749C126322002 @default.
• W2018093749 hasConceptScore W2018093749C134018914 @default.
• W2018093749 hasConceptScore W2018093749C141071460 @default.
• W2018093749 hasConceptScore W2018093749C2776106345 @default.
• W2018093749 hasConceptScore W2018093749C2776513394 @default.

• next